- Ocular Therapeutix (NASDAQ:OCUL) initiated with Overweight rating and $35 (387% upside) price target by Cantor Fitzgerald. Shares up 7% premarket on average volume.
- Teva Pharmaceutical Industries (NYSE:TEVA) downgraded to Underperform from Neutral with a $27 (16% downside risk) price target by Mizuho Securities. Shares down 1% premarket on average volume.
- Cerner (NASDAQ:CERN) downgraded to Market Perform from Outperform by Oppenheimer. Downgraded to Market Perform with $45 (16% downside risk) price target by Avondale. Canaccord Genuity reiterates Buy rating and $59 (10% upside) price target. Shares down 6% premarket on light volume.
- TESARO (NASDAQ:TSRO) price target increased to $232 (24% upside) from $151 by Citigroup. Buy rating and $190 (2% upside) price target reiterated by SunTrust Robinson Humphrey. Downgraded to Market Perform with $186 (0% upside) price target by Leerink Swann. Shares up a fraction premarket.